← Back to all trials
Not Yet Recruiting
NCT05725252
To Evaluate the Safety and the Pharmacokinetics of NVP-2203
Conditions: Healthy Volunteers
Sex: All
Ages: 19 Years – N/A
Healthy volunteers: 1
Phase: PHASE1
Enrollment: 50
Sponsor: NVP Healthcare
Location: Korea, Republic of
Summary
The purpose of this study is to evaluate the safety and pharmacokinetics after administration of NVP-2203.
Eligibility Criteria
Inclusion Criteria:Healthy adult subjects who signed informed consentBMI of >18.0 kg/m2 and <30.0 kg/m2 subject, weight more than 50kg(45 kg or more for woman)Exclusion Criteria:Subjects participated in another clinical trial within 6 months prior to administration of the study drugInadequate subject for the clinical trial by the investigator's decision
Source: ClinicalTrials.gov (NCT05725252). StuddyBuddy aggregates publicly available trial information.
